Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells-Reference-Cited by-同舟云学术

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells

Published:2023-05-05 Issue:8 Volume:82 Page:1117-1120
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Bergmann Christina^ORCID,Müller Fabian^ORCID,Distler Jörg H W^ORCID,Györfi Andrea-Hermina^ORCID,Völkl Simon,Aigner Michael,Kretschmann Sascha,Reimann Hannah,Harrer Thomas,Bayerl Nadine,Boeltz Sebastian^ORCID,Wirsching Andreas,Taubmann Jule,Rösler Wolf,Spriewald Bernd,Wacker Jochen,Atzinger Armin,Uder Michael,Kuwert Torsten,Mackensen Andreas,Schett Georg^ORCID

Funder

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

IZKF Erlangen

German Federal Ministry of Education and Research

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference8 articles.

1. Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells;Sato;Arthritis Rheumatol,2004

2. Safety and efficacy of Rituximab in systemic sclerosis (DESIRES): A double-blind, investigator-initiated, randomised, placebo-controlled trial;Ebata;The Lancet rheumatology,2021

3. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): A double-blind, double-dummy, randomised, controlled, phase 2B trial;Maher;Lancet (London, England),2023

4. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

5. CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature review;Journal of Neurology;2024-09-14

2. Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases;Immunological Reviews;2024-09-09

3. CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy;Joint Bone Spine;2024-09

4. Frontiers in CAR-T cell therapy for autoimmune diseases;Trends in Pharmacological Sciences;2024-09

5. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis;Cell;2024-09